Ballast Asset Management’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-745,030
Closed -$1.05M 53
2025
Q3
$1.05M Buy
745,030
+306,624
+70% +$935K 0.48% 53
2025
Q2
$1.96M Hold
438,406
1.02% 49
2025
Q1
$1.99M Buy
438,406
+6,519
+2% +$35.9K 1.05% 45
2024
Q4
$2.62M Buy
431,887
+82,187
+24% +$561K 1.3% 35
2024
Q3
$2.75M Buy
349,700
+31,450
+10% +$317K 1.41% 34
2024
Q2
$3.57M Buy
318,250
+20,129
+7% +$235K 1.94% 22
2024
Q1
$3.77M Buy
298,121
+27,522
+10% +$362K 2.04% 23
2023
Q4
$3.72M Buy
270,599
+74,836
+38% +$875K 2.37% 13
2023
Q3
$2.21M Buy
+195,763
New +$2.35M 2.05% 21

Other funds holding BIOX

Ballast Asset Management's BIOX Position: Q4 2025 in Review

Ballast Asset Management sold out of Bioceres Crop Solutions (BIOX) in Q4 2025, closing a stake of 745,030 shares — an estimated $1.05M sold.

Ballast Asset Management first reported a position in BIOX in Q3 2023 and held it in 9 quarters. The position peaked at $3.77M in Q1 2024. 37 funds tracked by Wall St. Rank hold BIOX as of Q4 2025.

  • Ballast Asset Management reported no remaining Bioceres Crop Solutions position as of Q4 2025 after selling out during the quarter.
  • Ballast Asset Management sold 745,030 Bioceres Crop Solutions shares in Q4 2025, an estimated $1.05M.
  • Ballast Asset Management first reported a position in Bioceres Crop Solutions in Q3 2023 and held it in 9 quarters.
  • Ballast Asset Management's Bioceres Crop Solutions position peaked at $3.77M in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2025.

Based on Ballast Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.